Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ku Huang granules vs S-adenosylmethionine for drug-induced liver injury
ChiCTR2500110157Phase 2Not yet recruiting
- Sponsor
- Longhua Hospital Shanghai University of Traditional Chinese Medicine
- Start
- Oct 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Ku Huang granules in Drug-induced hepatitis (DILI) (2 arms), sponsored by Longhua Hospital Shanghai University of Traditional Chinese Medicine. Primary endpoint: Recovery rate of liver function after 2 weeks and 4 weeks of treatment. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
Ku Huang granules
03
Conditions
Drug-induced hepatitis (DILI)
Beyond the preview
Go deeper on ChiCTR2500110157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110157.